8-K ·Filed May 11, 2026

WST

WEST PHARMACEUTICAL SERVICES INC
BEARISH
Impact 7/10
Horizonweeks Processed4mo ago SEC0000105770-26-000068
8-K Item 1.05: Material cybersecurity incident (mandatory SEC disclosure)
Actionable Insight ▼ Bearish

Monitor for further disclosures on restoration timeline, data breach scope, and financial impact estimates. Expect potential earnings guidance withdrawal or reduction. Watch for class action lawsuits or regulatory investigations.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
WST ▲ +11.62% at T+60d
SHORT call ✗ call lost -11.62% · α vs SPY -7.51% · entry $311.82 → $348.06
Entry anchored
May 11, 2026
via day open
T+1d
+0.08%
call -0.08% · α +0.46%
$312.07
settled 5mo ago
T+5d
-2.38%
call +2.38% · α +2.46%
$304.41
settled 5mo ago
T+20d
+6.12%
call -6.12% · α -7.85%
$330.92
settled 4mo ago
T+60d
+11.62%
call -11.62% · α -7.51%
$348.06
settled 8w ago

Price Chart

Loading chart...

Executive Summary

West Pharmaceutical (WST) disclosed a material cybersecurity attack on May 7, 2026, with data exfiltration and system encryption discovered on May 4. Operations were temporarily disrupted globally; core systems and critical processes at some sites have been restored, but full recovery timeline is unknown. Financial impact is not yet determinable.

Key Facts

  • Material cybersecurity attack determined on May 7, 2026; intrusion detected May 4.
  • Data exfiltrated and systems encrypted; proactive shutdown and isolation of systems.
  • Global business operations temporarily disrupted; core enterprise systems restored, shipping/receiving/manufacturing restarted at some sites.
  • Investigation ongoing with Palo Alto Networks Unit 42 engaged.
  • Material financial impact not yet determined.

Financial Impact

Not yet quantified; potential remediation costs, business interruption losses, and regulatory penalties.

revenueoperatingIncomecashFlow

Risk Factors

  • Extended operational disruption could impact Q2 2026 revenue and margins.
  • Remediation costs and potential regulatory fines or litigation expenses.
  • Customer and partner trust erosion may affect future contracts.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
83% bullish (23 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000105770-26-000068
Document: westcompanyalertswebsite.htm0000105770-26-000068
Document: 0000105770-26-000068-index-headers.html0000105770-26-000068
Document: 0000105770-26-000068-index.html0000105770-26-000068
Document: 0000105770-26-000068.txt0000105770-26-000068
12 reports for WST
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+60▲ +16.33%Apr 23, 2026
Filters
Rows
Reports for WST — sortable, filterable
TypeNow
Jul 23, 2026
10w ago
8-K
BULLISH ★ 7/10
$355.48 $353.77▼ −0.48%▼ −3.79%$364.89 (+2.65%)
Jul 23, 2026
10w ago
Press Release
BULLISH ★ 7/10
$355.48 $353.77▼ −0.48%▼ −3.79%$364.89 (+2.65%)
Jul 7, 2026
12w ago
Press Release
NEUTRAL ★ 1/10
$356.08 $347.94▼ −2.29%▼ −3.62%$364.89 (+2.47%)
May 11, 2026
20w ago
8-K
BEARISH ★ 7/10
$311.82 $330.92▼ −6.12%▼ −7.85%$364.89 (−17.02%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (65h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access